Phagocytosis by neutrophils quenches the procoagulant activity of activated platelets
. | Time, seconds . |
---|---|
No platelets | 159.3 ± 17.3 |
Activated platelets (105/μL) | 87.3 ± 4.6* |
Activated platelets (105/μL) + neutrophils (5 × 103/μL) | 113.5 ± 3.1* |
+ neutrophils (10 × 103/μL) | 130.0 ± 4.4* |
+ neutrophils (20 × 103/μL) | 153.6 ± 5.9* |
+ neutrophils (20 × 103/μL) treated with cytochalasin D | 98.0 ± 5.5 |
. | Time, seconds . |
---|---|
No platelets | 159.3 ± 17.3 |
Activated platelets (105/μL) | 87.3 ± 4.6* |
Activated platelets (105/μL) + neutrophils (5 × 103/μL) | 113.5 ± 3.1* |
+ neutrophils (10 × 103/μL) | 130.0 ± 4.4* |
+ neutrophils (20 × 103/μL) | 153.6 ± 5.9* |
+ neutrophils (20 × 103/μL) treated with cytochalasin D | 98.0 ± 5.5 |
Platelests (100 × 103/μL) were activated with TRAP-6 for 2 minutes and then incubated for 1 minute at 37°C alone or in the presence of an equal volume of neutrophils, at a neutrophil:platelet ratio of 1:20, 1:10, or 1:5. Neutrophils at the 1:5 ratio were either untreated or pretreated with cytochalasin D to prevent actin-based cytoskeleton assembly. After addition of normal human plasma and of a 25 mM CaCl2 solution, the coagulation (recalcification) time was recorded and expressed as seconds (mean ± SEM of 5 different experiment performed in duplicate). The platelet phagocytosis by neutrophils was confirmed in parallel by flow cytometry. *P < .05 with respect to samples with activated platelets alone (by paired t test).